Griffith ramps up world-first malaria vaccine campaign

Griffith University’s fight towards a cure for one of the world’s most deadly diseases is edging closer after human clinical trials of a malaria vaccine developed by the Institute for Glycomics were a success.
Researchers have shown the world-first whole blood-stage malaria parasite vaccine PlasProtecT®, tested in collaboration with the Gold Coast University Hospital, is safe and induces an immune response in humans.
Now efforts are turning to an international fundraising campaign to enable further evaluation of the vaccine in clinical trials, before researchers can shift their focus to malaria endemic countries.
The Malaria Vaccine Project, officially launched by His Excellency General the Honourable Sir Peter Cosgrove AK MC (Retd), Governor-General of the Commonwealth of Australia, aims to raise $500,000 to get the research to the next stage through Rotary fundraising efforts.
Speaking at the Institute on Monday (March 27), Sir Cosgrove said the work represented Australian science and innovation at its very best.
“This is

Spread the love

See Full Post >>